unitedhealthcare glp-1 coverage MCT2D Recent Trends in GLP-1 Use

A phase 1 study to assess the safety, pharmacokinetics, and anti-tumor activity of the androgen receptor N-terminal domain inhibitor epi-506 in patients with metastatic castration-resistant prostate cancer

doi: 10.1097/HCO.0000000000000404 83 MirLMGehlJSersaGCollinsCGGarbayJ-RBillardVet al

The main alternative there is minoxidil, and GHK-Cu doesnt cause the same side effects there either (facial hair growth, scalp irritation, shedding)

But the specifics depend on your formulation type

Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation

Ufnalska I, Drew SC, Zhukov I, Szutkowski K, Wawrzyniak UE, Wroblewski W, et al